1
|
Pandey S, Pareek V, Kumar R, Gupta A, Kunhiparambath H, Shalimar, Gamanagatti S, Gupta S, Sharma S, Binjola A, Kumar R, Pattanaik J, Praveen DVS, Sanyal S, Tanwar MS, Yadavalli P, Goel V, Roy S, Das N, Sisodiya R. Role of Stereotactic Body Radiation Therapy in Portal Vein Tumor Thrombosis in Hepatocellular Carcinoma: A Prospective Single Institute Experience. Int J Radiat Oncol Biol Phys 2023; 117:e330-e331. [PMID: 37785168 DOI: 10.1016/j.ijrobp.2023.06.2381] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Patients diagnosed with Hepatocellular carcinoma (HCC) complicated with portal vein tumor thrombosis (PVTT) have a limited number of treatment options available and are associated with an overall poor prognosis. With the recent developments in the field of radiation therapy, the role of radiotherapy particularly Stereotactic Body radiotherapy (SBRT) has increased as a loco-regional therapy for HCC. This study was planned to evaluate the role of SBRT in Locally advanced HCC complicated with PVTT and its role as loco-regional therapy. MATERIALS/METHODS We conducted a prospective study that included patients diagnosed with HCC complicated with PVTT Child-Turcotte Pugh (CTP) Class A/B with a maximum score of 7, diagnosed on triple phase Contrast-Enhanced - MRI unsuitable for other ablative procedures. Patients with Bilirubin levels > 4 mg/dl, active Hepatitis, CTP score >7, normal liver volume <700cc or history of prior radiotherapy were excluded from the study. Patients underwent a contrast enhanced 4D-CT simulation with abdominal compression and were planned for SBRT using VMAT technique. Patients were followed-up as per Institute protocol. CECT or MRI for a radiological response was done for response assessment using mRECIST criteria version 1.1. A baseline MRI was done at one-month post-SBRT to understand any RT changes in the liver and to differentiate from tumor progression during the response assessment at three months. RESULTS A total of 22 patients with HCC were recruited and received SBRT to PVTT, with a dosage between 30-42 Gy over 6 fractions treated on alternate days. Patients were assessed post-treatment with triphasic CE-MRI every 3 months as per institute protocol. Five patients had achieved Complete response in form of Portal vein recanalization. Three patients had Partial response to the treatment. Seven patients maintained stable disease status whereas six patients had disease progression during the entire course of treatment. The response rate (CR+PR) to treatment was 36.3% at the time of analysis. The Overall Response rate (CR+PR+SD) was 69%. No grade 3 or 4 toxicities were observed and treatment was tolerated well by patients. Kaplan-Meier method was applied to calculate the survival probability at various follow-up intervals. The median time for overall survival was 25 months ((95% CI: 15-35). Out of the 22 subjects included in the study, 6 patients died. There was a 78% survival probability at 12 months and a 68% survival probability at 18 months of follow-up. CONCLUSION This prospective single-arm study demonstrated the vital role of SBRT in the treatment of Hepatocellular carcinoma with Portal vein tumor thrombosis and its efficacy in terms of achieving excellent local control with relatively lesser toxicities compared with existing treatment modalities. Patients have shown benefit post-treatment in terms of thrombus reduction and restoration of Portal vein flow making them suitable for further treatment like Resection or TACE.
Collapse
Affiliation(s)
- S Pandey
- All India Institute of Medical Sciences, New Delhi, India
| | - V Pareek
- All India Institute of Medical Sciences, New Delhi, India
| | - R Kumar
- All India Institute of Medical Sciences, New Delhi, India
| | - A Gupta
- All India Institute of Medical Sciences, New Delhi, India
| | | | - Shalimar
- All India Institute of Medical Sciences, New Delhi, India
| | - S Gamanagatti
- All India Institute of Medical Sciences, New Delhi, India
| | - S Gupta
- All India Institute of Medical Sciences, New Delhi, India
| | - S Sharma
- All India Institute of Medical Sciences, New Delhi, India
| | - A Binjola
- All India Institute of Medical Sciences, New Delhi, India
| | - R Kumar
- All India Institute of Medical Sciences, Delhi Cancer Registry, New Delhi, India
| | - J Pattanaik
- All India Institute of Medical Sciences, New Delhi, India
| | - D V S Praveen
- All India Institute of Medical Sciences, New Delhi, India
| | - S Sanyal
- All India Institute of Medical Sciences, New Delhi, India
| | - M S Tanwar
- All India Institute of Medical Sciences, New Delhi, India
| | - P Yadavalli
- All India Institute of Medical Sciences, New Delhi, India
| | - V Goel
- All India Institute of Medical Sciences, New Delhi, India
| | - S Roy
- All India Institute of Medical Sciences, New Delhi, India
| | - N Das
- All India Institute of Medical Sciences, New Delhi, India
| | - R Sisodiya
- All India Institute of Medical Sciences, New Delhi, India
| |
Collapse
|
2
|
Pandey S, Pareek V, Kumar R, Gupta A, Kunhiparambath H, Shalimar, Gamanagatti S, Gupta S, Sharma A, Sharma S, Binjola A, Kumar R, Pattanaik J, Sanyal S, Praveen DVS, Tanwar MS, Mandal S, Shyam G, Das N, Goel V. Biological Response Assessment in Hepatocellular Carcinoma Post Stereotactic Body Radiotherapy. Int J Radiat Oncol Biol Phys 2023; 117:e331. [PMID: 37785169 DOI: 10.1016/j.ijrobp.2023.06.2382] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Biological Response in Hepatocellular carcinoma (HCC) is measured in terms of serum alpha-fetoprotein (AFP) which is elevated in nearly 60% HCC patients at baseline and is directly related to the severity of the disease. This biological response is defined as the reduction of more than 50% from the baseline levels and is associated with an increased percentage of tumor necrosis and is directly related to increased loco-regional control. Patients diagnosed with HCC have very limited treatment modalities. With the recent advances in the field of radiation therapy and the development of Stereotactic Body radiotherapy (SBRT), the role of radiotherapy has increased as a loco-regional modality for HCC. In this single-arm prospective study, we evaluated the biological response post-SBRT in patients diagnosed with HCC. MATERIALS/METHODS We conducted a prospective study that included patients diagnosed with HCC with baseline elevation of serum AFP, Child-Turcotte Pugh (CTP) Class A/B with a maximum score of 7. Patient's serum AFP levels were recorded at baseline, pre-treatment, and post-treatment. The biological response was measured at 3 months post-treatment and compared with the baseline serum AFP levels using Wilcoxon signed rank test. RESULTS A total of 14 patients with HCC were recruited and received SBRT to the target lesion, with a dose between 30-42 Gy over 6 fractions treated on alternate days. Patients were assessed post-treatment at one month with triphasic CEMRI and serum AFP levels. 12 out of 14 patients (85.71%) had a biological response at 3 months follow-up and levels showed further decline unless a progression was found. The median (IQR) serum AFP level was 1131 ng/ml (359-5668 ng/ml) at baseline. Post-treatment serum AFP levels had a median (IQR) value of 156 ng/ml (15-372 ng/ml) showing a near reduction of 86% from baseline, which was significant. 2/14 pts (14.28%) showed no reduction or even increase in serum AFP levels post-treatment. CONCLUSION This prospective single-arm study demonstrated the vital role of SBRT in the treatment of HCC and its importance in achieving a better disease control. The response was achieved in 86% of patients with marked reduction of nearly 90% in serum AFP levels as compared to the baseline and increased median OS and PFS as compared to patients not receiving radiotherapy. Further prospective studies are warranted to confirm our findings.
Collapse
Affiliation(s)
- S Pandey
- All India Institute of Medical Sciences, New Delhi, India
| | - V Pareek
- All India Institute of Medical Sciences, New Delhi, India
| | - R Kumar
- All India Institute of Medical Sciences, New Delhi, India
| | - A Gupta
- All India Institute of Medical Sciences, New Delhi, India
| | | | - Shalimar
- All India Institute of Medical Sciences, New Delhi, India
| | - S Gamanagatti
- All India Institute of Medical Sciences, New Delhi, India
| | - S Gupta
- All India Institute of Medical Sciences, New Delhi, India
| | - A Sharma
- All India Institute of Medical Sciences, New Delhi, India
| | - S Sharma
- All India Institute of Medical Sciences, New Delhi, India
| | - A Binjola
- All India Institute of Medical Sciences, New Delhi, India
| | - R Kumar
- All India Institute of Medical Sciences, Delhi Cancer Registry, New Delhi, India
| | - J Pattanaik
- All India Institute of Medical Sciences, New Delhi, India
| | - S Sanyal
- All India Institute of Medical Sciences, New Delhi, India
| | - D V S Praveen
- All India Institute of Medical Sciences, New Delhi, India
| | - M S Tanwar
- All India Institute of Medical Sciences, New Delhi, India
| | - S Mandal
- All India Institute of Medical Sciences, New Delhi, India
| | - G Shyam
- All India Institute of Medical Sciences, New Delhi, India
| | - N Das
- All India Institute of Medical Sciences, New Delhi, India
| | - V Goel
- All India Institute of Medical Sciences, New Delhi, India
| |
Collapse
|
3
|
Panda TK, Singhai K, Nebhinani N, Pareek V, Jain S. Diagnostic and Therapeutic Challenges in an Adolescent with Comorbid Oppositional Defiant Disorder and Bipolar Disorder. Journal of Indian Association for Child and Adolescent Mental Health 2023. [DOI: 10.1177/09731342231156497] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/14/2023]
Abstract
Oppositional defiant disorder (ODD) is often found to be comorbid with bipolar disorder (BD) in children and adolescents. Both disorders are characterized by chronic irritability, emotional dysregulation, and behavioral problems. These overlapping symptoms often lead to diagnostic difficulty. In addition, ODD-BD comorbidity also presents multiple therapeutic challenges. Here, we describe the case of an adolescent male, who presented with comorbid ODD and BD, along with multiple diagnostic and therapeutic challenges.
Collapse
Affiliation(s)
- Tushar Kanta Panda
- Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
| | - Kartik Singhai
- Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
| | - Naresh Nebhinani
- Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), Jodhpur, Rajasthan, India
| | - Vrinda Pareek
- Department of Psychiatry, Medical College, Baroda, Gujarat, India
| | | |
Collapse
|
4
|
Devnani B, Noronha V, Sirohi B, Bambury K, George R, Pareek V, Morgan G. 429P Cancer and COVID-19 in India: Assessing the impact in a nationwide survey. Ann Oncol 2022. [PMCID: PMC9719675 DOI: 10.1016/j.annonc.2022.10.460] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/07/2022] Open
Affiliation(s)
- B. Devnani
- Department of Radiation Oncology, All India Institute of Medical Sciences, Jodhpur, India
| | - V. Noronha
- Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India
| | - B. Sirohi
- Department of Medical Oncology, Apollo Proton Cancer Centre, Chennai, Karnataka, India
| | | | | | - V. Pareek
- Department of Radiation Oncology, National Cancer Institute-AIIMS, Jhajjar, India
| | - G. Morgan
- Oncology Department, Skane University Hospital and Oncoalert Network, Lund, Sweden
| |
Collapse
|
5
|
Nebhinani N, Pareek V, Choudhary S, Tripathi S, Singh P, Kumar M. Pathways of care and attitudes toward psychotropics in patients with depressive disorders and psychotic disorders. J Neurosci Rural Pract 2022; 13:785-790. [PMID: 36743762 PMCID: PMC9893934 DOI: 10.25259/jnrp-2021-11-39] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2022] [Accepted: 09/27/2022] [Indexed: 11/19/2022] Open
Abstract
Objectives Delay in institution of appropriate mental healthcare is closely linked with attitudes, stigma, and availability of services, which further directs the help seeking pathways. This study was aimed to assess the pathway of care and attitudes toward psychotropic medications among patients with depressive disorder and psychotic disorders. Materials and Methods Eighty outpatients with depressive disorder and 40 patients with psychotic disorder were assessed in a tertiary care center for pathways to care and attitude toward psychotropics through Attitude toward Psychotropic Medications Questionnaire and Drug attitude inventory-10. Results The psychiatrist remained the most common first treatment contact (46% in depression and 62% in psychosis). Greater number of patients in psychotic disorder group had first treatment contact with faith healers or exorcist (17.5%), compared to depressive disorder (6.2%). Patients in depressive group had more favorable attitude toward psychotropics compared to psychosis group. Majority of patients had favorable attitude toward psychotropic medications, but they also had substantial misconceptions about side effects, utility, and need of taking lesser than prescribed doses. Conclusions Although majority of patients had favorable attitude, they also had substantial misconceptions about medications. These issues need to be addressed for better delivery of comprehensive mental healthcare.
Collapse
Affiliation(s)
- Naresh Nebhinani
- Department of Psychiatry, All India Institute of Medical Science, Jodhpur, Rajasthan, India
| | - Vrinda Pareek
- Department of Psychiatry, Government Medical College, Vadodara, Gujarat, India
| | - Swati Choudhary
- Department of Psychiatry, All India Institute of Medical Science, Jodhpur, Rajasthan, India
| | - Swapnil Tripathi
- Department of Medicine, All India Institute of Medical Science, Jodhpur, Rajasthan, India
| | - Prerna Singh
- Department of Psychiatry, All India Institute of Medical Science, Jodhpur, Rajasthan, India
| | - Manish Kumar
- Department of Psychiatry, All India Institute of Medical Science, Jodhpur, Rajasthan, India
| |
Collapse
|
6
|
Patel J, McGain F, Bhatelia T, Wang S, Sun B, Monty J, Pareek V. Vented Individual Patient (VIP) Hoods for the Control of Infectious Airborne Diseases in Healthcare Facilities. Engineering (Beijing) 2022; 15:126-132. [PMID: 35721872 PMCID: PMC9197795 DOI: 10.1016/j.eng.2020.12.024] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/24/2020] [Revised: 10/28/2020] [Accepted: 12/17/2020] [Indexed: 05/13/2023]
Abstract
By providing a means of separating the airborne emissions of patients from the air breathed by healthcare workers (HCWs), vented individual patient (VIP) hoods, a form of local exhaust ventilation (LEV), offer a new approach to reduce hospital-acquired infection (HAI). Results from recent studies have demonstrated that, for typical patient-emitted aerosols, VIP hoods provide protection at least equivalent to that of an N95 mask. Unlike a mask, hood performance can be easily monitored and HCWs can be alerted to failure by alarms. The appropriate use of these relatively simple devices could both reduce the reliance on personal protective equipment (PPE) for infection control and provide a low-cost and energy-efficient form of protection for hospitals and clinics. Although the development and deployment of VIP hoods has been accelerated by the coronavirus disease 2019 (COVID-19) pandemic, these devices are currently an immature technology. In this review, we describe the state of the art of VIP hoods and identify aspects in need of further development, both in terms of device design and the protocols associated with their use. The broader concept of individual patient hoods has the potential to be expanded beyond ventilation to the provision of clean conditions for individual patients and personalized control over other environmental factors such as temperature and humidity.
Collapse
Affiliation(s)
- J Patel
- CSIRO Energy, Melbourne, VIC 3169, Australia
| | - F McGain
- Western Health, Melbourne, VIC 3021, Australia
- School of Public Health, The University of Sydney, Sydney, NSW 2006, Australia
- Centre for Integrated Critical Care, The University of Melbourne, Melbourne, VIC 3010, Australia
| | - T Bhatelia
- The Western Australian School of Mines: Minerals, Energy and Chemical Engineering, Curtin University, Perth, WA 6102, Australia
| | - S Wang
- Department of Mechanical Engineering, City University of Hong Kong, Hong Kong 999077, China
| | - B Sun
- The Western Australian School of Mines: Minerals, Energy and Chemical Engineering, Curtin University, Perth, WA 6102, Australia
| | - J Monty
- Department of Mechanical Engineering, The University of Melbourne, Melbourne, VIC 3010, Australia
| | - V Pareek
- The Western Australian School of Mines: Minerals, Energy and Chemical Engineering, Curtin University, Perth, WA 6102, Australia
| |
Collapse
|
7
|
Sharma A, Bharat R, Pareek V, Vivekanandan A, Shyam G, Gosh V, Gupta S, Yadav J, Mullassery S, Bisht R, Patil P, Mallick S, Sharma D, Nirala S. PD-0559 Interstitial HDR Brachytherapy in head and neck carcinomas: experience in COVID pandemic. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02874-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
8
|
Barthwal M, Pareek V, Yadav J, Ms S, Bisht R, Patil P, Sharma A, Sharma D, V S, Mallick S. PO-1039 Assessment of Surface Guided Radiation therapy in Breast cancer: An Indian Experience. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)03003-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
9
|
Praveen D, Shyam G, Pareek V, Shishak S, Barthwal M, Pandey S, Nirala S, Sanyal S, Pattanaik J, Samala S, Tanwar M, Mandal S, A A, Bora D, Ravi A, Ghosh V, Solanki A, Sisodiya R, Dhamija E, Rastogi S, Barwad A, Sharma D, Pandey R. PO-1437 Clinical outcomes in adult primitive neuro-ectodermal tumor of kidney: A single institute experience. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)03401-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
10
|
Pattanaik J, Pareek V, Barthwal M, Sanyal S, Mandal S, Praveen D, Pandey S, Shyam G, Tanwar M, Bora D, Samala S, Nirala S, A A, Ghosh V, Ravi A, Solanki A, Sisodiya R, Sharma D, Gupta S, Kp H. PO-1168 Systematic Review and Individual Patient data in Lipoid Neurocytoma - Impact of Radiotherapy. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)03132-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
11
|
Ravi A, Pareek V, Barthwal M, Shyam G, A A, Bora D, Ghosh V, Sanyal S, Samala S, Tanwar M, Mandal S, Pandey S, Praveen D, Pattanaik J, Nirala S, Solanki A, Sisodiya R, Sharma S, Sharma D, Kp H, Gupta S. PO-1225 Cardiac substructures in hypofractionated treatment schedules in left sided breast cancer. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)03189-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
12
|
Gupta S, Kp H, Pareek V, Barthwal M, Bora D, Giridhar P, Devnani B, Julka P. PO-1155 Clinical outcome with radiotherapy in management of Craniopharyngioma: A Single institute experience. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)03119-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
13
|
Nebhinani N, Tripathi S, Suthar N, Pareek V, Purohit P, Sharma P. Correlates of Metabolic Syndrome in Patients with Schizophrenia: An Exploratory Study. Indian J Clin Biochem 2022; 37:232-237. [PMID: 35463100 PMCID: PMC8993960 DOI: 10.1007/s12291-020-00912-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2020] [Accepted: 06/27/2020] [Indexed: 11/28/2022]
Abstract
Metabolic syndrome (MS) is commonly reported in patients with severe mental illness including schizophrenia, but data is sparse from north-western India. The study was aimed to assess the metabolic profile in patients with schizophrenia. Patients with schizophrenia and healthy controls (N = 55 in each group) were recruited from psychiatric outpatient clinic and evaluated for the presence of metabolic syndrome using the modified National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP-III) criteria. Prevalence of MS was significantly greater in patient group (34.5%), compared to healthy controls (14.5%). Other 31 patients (56.4%) had one or two metabolic abnormalities. Most common metabolic abnormality was higher waist circumference in both the groups. Nearly half of the patients (56%) were obese. Greater age, weight, body mass index, and obesity were significantly associated with MS and similar variables were significant predictors of MS. MS was not associated with duration and severity of schizophrenia (PANSS score), attitude towards psychotropics (DAI-10 score), functionality (GAF score) and demographic variables. Metabolic abnormalities were significantly greater in patients with schizophrenia. It calls for comprehensive evaluation of the patients with schizophrenia, with timely management and effective prevention of metabolic problems.
Collapse
Affiliation(s)
- Naresh Nebhinani
- Department of Psychiatry, All India Institute of Medical Science, Jodhpur, Rajasthan 342005 India
| | - Swapnil Tripathi
- Department of Medicine, All India Institute of Medical Science, Jodhpur, Rajasthan India
| | - Navratan Suthar
- Department of Psychiatry, All India Institute of Medical Science, Jodhpur, Rajasthan 342005 India
| | - Vrinda Pareek
- Department of Psychiatry, Government Medical College, Vadodara, Gujarat India
| | - Priyanka Purohit
- Department of Psychiatry, All India Institute of Medical Science, Jodhpur, Rajasthan 342005 India
| | - Praveen Sharma
- Department of Biochemistry, All India Institute of Medical Science, Jodhpur, Rajasthan India
| |
Collapse
|
14
|
Pareek V, Bhalavat R, Chandra M, Nellore L, George K, Borade D. Clinical Outcomes and Toxicity Profile With IMRT or Brachytherapy Boost in Oropharyngeal Malignancies: A Randomized, Open Label Study. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
15
|
Barthwal M, Pareek V, Patil P, Mallick S, Sharma A, Sharma D. Music Therapy to Alleviate Anxiety in Cervical Brachytherapy – Do We Change a Tune? A Randomized, Single Institute Study. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.1626] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
16
|
Pareek V, Bhalavat R, Chandra M, Nellore L, George K, Borade D. OC-0023 IMRT or Brachytherapy boost in oropharyngeal malignancies: A Randomized, open label study. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)06276-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
17
|
Barthwal M, Pareek V, Giridhar P, Mallick S. OC-0061 Phase III randomized trial of trans-abdominal ultrasound in intra-cavitary brachytherapy in Cervix. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)06294-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
18
|
Pareek V, Chandra M, Bhalavat R. PO-0180 Impact of hybrid brachytherapy in cervical cancer: A survival and toxicity profile assessment. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)06339-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
19
|
Nebhinani N, Sharma P, Suthar N, Pareek V, Kunwar D, Purohit P, Purohit P. Correlates of metabolic syndrome in patients with depression: A study from north-western India. Diabetes Metab Syndr 2020; 14:1997-2002. [PMID: 33080542 DOI: 10.1016/j.dsx.2020.10.013] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/27/2020] [Revised: 06/19/2020] [Accepted: 10/11/2020] [Indexed: 01/01/2023]
Abstract
BACKGROUND AND AIMS Metabolic syndrome (MS) is found to be prevalent in patients with mental illness including depression. Data is sparse on the role of lifestyle factors on MS in depression. METHODS This study was aimed to assess correlates of MS in patients with depression. METHODOLOGY Three hundred eighty-two patients with depressive disorders were assessed for the prevalence of MS by using modified National Cholesterol Education Program- Adult Treatment Panel-III criteria (NCEP ATP-III). Their illness severity, functionality, physical activity and nutritional habits were also assessed. CONCLUSIONS Majority of patients with depression (82.2%) were drug naive. One-fourth of the patients had metabolic syndrome (27.7%). Additionally, other 59% of patients had one or two metabolic abnormalities and one-third of patients were obese. Lower high density lipoprotein cholesterol level was the most common abnormality (65%), while abnormal blood pressure was the least common abnormality (18%). Significant correlates of MS were greater age, and age at onset of depression, greater illness duration, lesser physical activity and lower nutritional score. CONCLUSION Nearly one-fourth of patients with depression had MS; another three-fifth of patients had one or two metabolic abnormalities. MS was more commonly seen with sedentary lifestyle and poor nutritional habits. It calls for comprehensive assessment and timely management of cardiovascular risk factors as well as lifestyle factors in depression.
Collapse
Affiliation(s)
- Naresh Nebhinani
- Department of Psychiatry, All India Institute of Medical Science, Jodhpur, Rajasthan, India.
| | - Praveen Sharma
- Department of Biochemistry, All India Institute of Medical Science, Jodhpur, Rajasthan, India
| | - Navratan Suthar
- Department of Psychiatry, All India Institute of Medical Science, Jodhpur, Rajasthan, India
| | - Vrinda Pareek
- Department of Psychiatry, Government Medical College, Vadodara, Gujarat, India
| | - Deep Kunwar
- Department of Psychiatry, All India Institute of Medical Science, Jodhpur, Rajasthan, India
| | - Priyanka Purohit
- Department of Psychiatry, All India Institute of Medical Science, Jodhpur, Rajasthan, India
| | - Purvi Purohit
- Department of Biochemistry, All India Institute of Medical Science, Jodhpur, Rajasthan, India
| |
Collapse
|
20
|
Pareek V, Bhalavat R, Chandra M, Bauskar P, Kumar N, Kotilingala E, Iyer P. PO-0965: Cardiac dosimetry with or without ABC in left breast cancer irradiation: Single institute experience. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00983-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
21
|
Kapoor A, Bhalavat R, Chandra M, Bakshi C, Bauskar P, Kumar N, Markana S, Amar S, Pareek V. Assessment of Impact of Bone Marrow Sparing for Hematological and Gastrointestinal Toxicities in Cervical Cancer with External Beam Radiation Therapy. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.2305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
22
|
Pareek V, Bhalavat R, Chandra M, Nellore L, George K, Borade D, Bauskar P. Clinical outcomes and Toxicity profile with IMRT or Brachytherapy boost in oropharyngeal malignancies: A Randomized, open label study. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2019.11.394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
23
|
Pareek V. PO-157: Predictive factors and survival outcomes with SBRT in oligometastases in colorectal cancer. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(20)30499-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
24
|
Pareek V, Chandra M, Bhalavat R, Kumar N, George K, Nellore L, Borade D. OC-084: Hybrid Brachytherapy in locally advanced Cervical cancer: A Survival and toxicity profile assessment. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(20)30453-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
25
|
Pareek V, Chandra M, Bhalavat R, Ambekar U, John S, Jain D, Iyer L. OC-085: Role of intervention-Patient reported sexual adjustment following brachytherapy for cervical cancer. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(20)30454-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
26
|
Pareek V, Bhalavat R, Chandra M. Hippocampal avoidance in WBRT for metastases: Comparative neurocognitive and dosimetric assessment. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz419.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
27
|
Pareek V. Predictive factors and survival outcomes with stereotactic body radiation therapy in treatment of oligometastases in colorectal cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz430.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
28
|
Pareek V, Bhalavat R, Chandra M. Impact of combined interstitial and intracavitary brachytherapy in locally advanced cervical cancer: A survival and toxicity profile assessment. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz426.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
29
|
Pareek V, Bhalavat R, Chandra M. Ventricular–Subventricular zone involvement: A predictive factor for survival in glioblastoma. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz431.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
30
|
Pareek V, Chandra M, Bhalavat R. Impact of combined interstitial and intracavitary brachytherapy in locally advanced cervical cancer: A survival and toxicity profile assessment. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz250.058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
31
|
Razaq M, Pareek V, Srivastava A, Ramesh R. P2.01-83 Role of Exosomal MicroRNAs (miRNAs) as Predictors of Response to Treatment and Prognosis in Non-Small Cell Lung Cancer (NSCLC). J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1426] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
32
|
Pareek V, Bhalavat R, Chandra M. Predictive factors and survival outcomes with stereotactic body radiation therapy in treatment of oligometastases in colorectal cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz246.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
33
|
Pareek V, Bhalavat R, Chandra M. Spirituality and religious coping for cancer patients and providers: An ‘Almighty’ belief for palliative care. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz261.010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
34
|
Jain S, Singhai K, Pareek V, Nebhinani N. Comprehensive antenatal to postpartum care of patient with bipolar disorder: a case report. Case Reports in Perinatal Medicine 2019. [DOI: 10.1515/crpm-2018-0057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract
Background
The management of women with bipolar disorder during the pregnancy period is a challenging task, as such patients are at a higher risk of relapse during the pregnancy and the early postpartum period. No approach is without risk and clinicians are faced with difficult choices at every turn.
Case presentation
We present a case of a female with bipolar disorder, who presented with mania during the second trimester and we faced several challenges in her treatment during pregnancy, post-partum and the subsequent follow-up period.
Conclusion
For a favourable outcome to both mother and child, prenatal care providers can have individualised discussions regarding mental health issues in addition to neonatal risks from bipolar disorder and/or medications side effects and facilitating liaisons with health professionals to manage the complications and associated risks.
Collapse
Affiliation(s)
- Shreyance Jain
- Department of Psychiatry , All India Institute of Medical Sciences , Jodhpur, Rajasthan 342005 , India , Tel.: +91-9571687799
| | - Kartik Singhai
- Department of Psychiatry , All India Institute of Medical Sciences , Jodhpur, Rajasthan 342005 , India
| | - Vrinda Pareek
- Department of Psychiatry , All India Institute of Medical Sciences , Jodhpur, Rajasthan 342005 , India
| | - Naresh Nebhinani
- Department of Psychiatry , All India Institute of Medical Sciences , Jodhpur, Rajasthan 342005 , India
| |
Collapse
|
35
|
Chandra M, Pareek V, Kumar N, Bhalavat R, George K, Nellore L, Bauskar P. Impact of Combined Interstitial and Intracavitary Brachytherapy in Locally Advanced Cervical Cancer: A Feasibility, Survival, and Toxicity Profile Assessment. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1798] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
36
|
Devnani B, Gupta S, Haresh K, Biswas A, Pareek V, Batra M, Singh M, Tandon V, Julka P, Rath G. Impact of Adjuvant Therapy on Survival in Treatment of Central Nervous System Hemangiopericytoma. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.2224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
37
|
Pareek V, Bhalavat R, Chandra M. Predictive factors and survival outcomes with stereotactic body radiation therapy in treatment of oligometastases in colorectal cancer. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.05.055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
38
|
Abstract
In the last few years, a cluster of anatomical discoveries has been reported which overturned the long existing dogmas about the structure and function of human body. First to come was the discovery that established the existence of a lymphatic system pertaining to the central nervous system (CNS). CNS was believed to be anatomically immune privileged owing to the absence of any lymphatics and presence of the blood-brain barrier around it, but latest research has established beyond any reasonable doubt that true lymphatic channels carry immune cells in meninges thus challenging the existing theory. Studies also supported the presence of a 'Glymphatic system' (created by the perivascular spaces lined with the leptomeninges and a sheath of glial cells) in the CNS draining interstitial metabolic waste from CNS. The second discovery unraveled the previously unknown parts of the human mesentery in adult and established that it is a continuous entity all along the intra-abdominal gut tube against the previous notion that it is fragmented in the adult humans. A very recently reported third discovery demonstrated a previously unknown tissue component-'interstitium'-a networked collagen bound fluid-filled space existent in a number of human organs. All these structures bear considerable applied importance towards the pathogenesis, prognostic and diagnostic investigations and management of human diseases. This article attempts to present a brief review of all three remarkable discoveries and emphasizes their applied importance within the realm of medical sciences.
Collapse
Affiliation(s)
- A Kumar
- From the Department of Anatomy, All India Institute of Medical Sciences (AIIMS), Patna, India
| | - S K Ghosh
- From the Department of Anatomy, All India Institute of Medical Sciences (AIIMS), Patna, India
| | - M A Faiq
- Neuroimaging and Visual Science Laboratory, Langone Medical Centre, New York University School of Medicine, NY, USA
| | - V R Deshmukh
- Department of Anatomy, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Karaikal, India
| | - C Kumari
- Department of Anatomy, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
| | - V Pareek
- Computational Neuroscience and Neuroimaging Division, National Brain Research Centre (NBRC), Manesar, India
| |
Collapse
|
39
|
Nebhinani N, Sharma P, Pareek V, Suthar N, Jakhotia S, Gehlot M, Purohit P. Association of Inflammatory and Liver Markers with Cardiometabolic Risk Factors in Patients with Depression. Indian J Clin Biochem 2019; 34:219-224. [PMID: 31092997 DOI: 10.1007/s12291-018-0738-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2017] [Accepted: 02/08/2018] [Indexed: 11/27/2022]
Abstract
Metabolic syndrome (MS) is found to be more prevalent in patients with psychiatric disorders including depression. This study aimed to assess the association of inflammatory and liver markers with cardiometabolic risk factors in patients with Depressive disorders. Prevalence of MS by using Modified NCEP ATP-III Criteria and liver enzymes and CRP were assessed in 382 patients with depressive disorders. MS prevalence was 27.7% and lower HDL level was the commonest metabolic abnormality. ALT, GGT, and CRP levels were positively correlated with weight and BMI. ALT, GGT, and CRP levels were significantly greater in patients with abnormal waist circumference, triglyceride levels and raised blood pressure, compared to patients with normal indices. Such association was not found with abnormal HDL cholesterol and hyperglycemia. Levels of GGT and CRP were significantly greater in patients with MS compared to patients without MS and CRP was significant predictor for MS. To conclude, one-fourth of depressed patients had MS. MS and metabolic abnormalities were associated with inflammatory marker and liver enzymes. Patients with depression should be regularly evaluated for cardiovascular risk factors, liver enzymes, and inflammatory markers.
Collapse
Affiliation(s)
- Naresh Nebhinani
- 1Department of Psychiatry, All India Institute of Medical Science, Jodhpur, Rajasthan 342005 India
| | - Praveen Sharma
- 2Department of Biochemistry, All India Institute of Medical Science, Jodhpur, Rajasthan 342005 India
| | - Vrinda Pareek
- 1Department of Psychiatry, All India Institute of Medical Science, Jodhpur, Rajasthan 342005 India
| | - Navratan Suthar
- 1Department of Psychiatry, All India Institute of Medical Science, Jodhpur, Rajasthan 342005 India
| | - Shobhan Jakhotia
- 1Department of Psychiatry, All India Institute of Medical Science, Jodhpur, Rajasthan 342005 India
| | - Mukesh Gehlot
- 1Department of Psychiatry, All India Institute of Medical Science, Jodhpur, Rajasthan 342005 India
| | - Purvi Purohit
- 2Department of Biochemistry, All India Institute of Medical Science, Jodhpur, Rajasthan 342005 India
| |
Collapse
|
40
|
Pareek V, Bhalavat R, Chandra M, Bakshi C, Bhambhani N. EP-2128 Rectal toxicity with MUPIT Interstitial Brachytherapy – Predictors, clinical and dosimetric outcomes. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)32548-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
41
|
Pareek V. Assessment of toxicity and clinical outcomes with SBRT in lung metastases: A single institute experience. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz068.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
42
|
Pareek V, Bhalavat R, Chandra M. EP-1263 Hippocampal avoidance in WBRT for Metastases – Comparative Neurocognitive and Dosimetric Assessment. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31683-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
43
|
Pareek V, Bhalavat R, Chandra M, Bakshi C, Bhambhani N. PO-1060 Role of intraluminal brachytherapy as palliative treatment in advanced esophageal cancer. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31480-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
44
|
Pareek V, Bhalavat R, Chandra M. PO-092 Can Brachytherapy help reduce the dose to DARS in Head and Neck cancer? A Clinical experience. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)30258-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
45
|
Pareek V, Bhalavat R, Chandra M, Nellore L, George K, Borade D, Kalariya K, Moosa Z, Reddy N, Srivastava A, Kapoor A, Kawale D, Bauskar P. PO-100 HDR Interstitial brachytherapy in Recurrent Head and Neck cancer: An effective Salvage option. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)30266-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
46
|
Pareek V. PO-088 Assessment of acute toxicities in nasopharyngeal carcinoma with IMRT - A tale of two contours. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)30254-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
47
|
Gupta T, Singhai K, Swami M, Nebhinani N, Jain S, Pareek V. Emerging personality disorder in adolescence: Diagnostic dilemma and therapeutic challenges. Asian J Psychiatr 2019; 40:60-61. [PMID: 30738378 DOI: 10.1016/j.ajp.2019.01.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/11/2019] [Revised: 01/29/2019] [Accepted: 01/31/2019] [Indexed: 11/16/2022]
Affiliation(s)
- Tanu Gupta
- Dept. of Psychiatry, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
| | - Kartik Singhai
- Dept. of Psychiatry, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
| | - Mukesh Swami
- Dept. of Psychiatry, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
| | - Naresh Nebhinani
- Dept. of Psychiatry, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
| | - Shreyance Jain
- Dept. of Psychiatry, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
| | - Vrinda Pareek
- Dept. of Psychiatry, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
| |
Collapse
|
48
|
Pareek V. Hippocampal Avoidance in Whole Brain Radiation Therapy for Metastases – Comparative Neurocognitive and Dosimetric Assessment. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.917] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
49
|
Pareek V, Bhalavat R, Chandra M, Bakshi C, Kanbur R. EP-1242: Prognostic role of PET/CT in DLBCL - assessment of Deauville criteria and SUV max. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31552-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
50
|
Pareek V, Bhalavat R, Chandra M, Nellore L, George K, Borade D, Kalariya K, Moosa Z, Navaneeth R, Amrita S, Kapoor A, Bakshi C. EP-1241: Assessment of Quality of Life in Elderly and young DLBCL: Risk Parameters and clinical outcomes. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31551-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|